Sosei Heptares Acquires Idorsia's Pharmaceuticals Business

Transaction adds complementary late-stage clinical development capability with profitable and fast-growing commercial operations in JapanLean, go-to-market...

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Switzerland ,Singapore ,Tokyo ,Japan ,Philippines ,Laos ,Malaysia ,Taiwan ,New Zealand ,Indonesia ,Brunei ,Australia ,South Korea ,Vietnam ,Republic Of ,Cambodia ,Thailand ,Mochida ,Miyazaki ,London ,City Of ,China ,Mizuho ,Hokkaido ,Japanese ,Swiss ,South Korean ,Neurocrine Biosciences ,Sosei Heptare ,Sosei Heptares ,Hironoshin Nomura ,Shinichiro Nishishita ,Maya Bennison ,Satoshi Tanaka ,Frazer Hall ,Shinichi Tamura ,Chris Cargill ,Genentech Roche ,Herrington Sutcliffe ,Linkedin ,Idorsia Pharmaceuticals Japan Ltd ,Idorsia Pharmaceutical Ltd ,Sosei Group Corporation ,Novartis ,Youtube ,Medistrava Consulting For International Media ,Tokyo Stock Exchange ,Centerview Partners United Kingdom ,Idorsia Ltd ,Johnson ,Twitter ,Idorsia Pharmaceuticals Korea Co Ltd ,Sosei Group ,Swiss Exchange ,Sosei Group Corporation The Company ,Mizuho Bank ,Pfizer ,Sosei Group As Representative ,Actelion Pharmaceuticals Ltd ,Heptares Therapeutics ,Representative Director ,Executive Officer ,Inflammatory Bowel Disease ,Global Use ,Actelion Pharmaceuticals ,Chief Financial Officer ,International Media ,Japan Exchange Group Soltf ,